Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 77.00 | |
5 mg | In stock | $ 189.00 | |
10 mg | In stock | $ 296.00 | |
25 mg | In stock | $ 592.00 | |
50 mg | In stock | $ 845.00 | |
100 mg | In stock | $ 1,170.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 222.00 |
Description | IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression |
In vitro | IMM-H007 (H007) significantly inhibits monocyte adhesion to endothelial cells and its transendothelial migration.?Mechanistically, H007 markedly represses TNFα-induced IκBα degradation and NF-κB nuclear translocation, therefore leading to NF-κB-mediated inflammatory suppression.?Moreover, another inflammatory signaling JNK/c-Jun, which is always co-activated with NF-κB in response to pro-inflammatory stimuli, is also found to be restrained by H007 through reducing its phosphorylation status.?H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. |
Molecular Weight | 485.45 |
Formula | C22H23N5O8 |
CAS No. | 1221412-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (60.91 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IMM-H007 1221412-23-2 Chromatin/Epigenetic Others PI3K/Akt/mTOR signaling AMPK JNK Nuclear factor-κB WS 070117 IMM H007 AP-1 inflammatory WS070117 inhibit atherosclerosis Transforming growth factor beta receptors Activator Protein 1 cardiac fibrosis IMM-H 007 JNK/c-Jun IMMH007 IMM-H-007 NF-κB Nonalcoholic fatty liver disease NAFLD WS-070117 TGF-β Receptor AMP-activated protein kinase Nuclear factor-kappaB Inhibitor inhibitor